Rhythmic sound may retrain the brain to walk better after TBI

NCT ID NCT07702513

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study tests whether a home-based device that uses rhythmic music to guide walking can help adults with moderate to severe traumatic brain injury improve their mobility, balance, and overall recovery. Participants use the MR-001 device at home for 30 minutes, three times a week for eight weeks, while researchers measure walking speed, balance, mood, and brain activity. The goal is to see if this approach is safe, enjoyable, and effective enough to support long-term recovery outside of a clinic.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a home-based rhythmic auditory stimulation device called MR-001
What this could lead to
If it works, this could offer a convenient, music-guided way to improve mobility and balance after traumatic brain injury, potentially aiding long-term recovery at home.
What could go wrong
This is a small pilot study with only 33 participants, so results may not apply broadly. The device may not lead to meaningful improvements, and home use could pose safety or adherence challenges.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TBI are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Brain Injuries, Traumatic traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Craig Hospital

    Englewood, Colorado, 80113, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.